GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Prostate | SK | Recruiting
PSMA-01
68Ga-PSMA PET/CT in Prostate Cancer
Dr. Rajan Rakheja
Start Date: December 9, 2020

NCT#:  NCT04684628

SPONSOR: University of Saskatchewan

INFO:  https://clinicaltrials.gov/ct2/show/NCT04684628

CONTACT:  306-655-3351

Bladder | ON, QC | Recruiting
SunRISe-2
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder (SunRISe-2)
Start Date: December 7, 2020

NCT #: NCT04658862

SPONSOR: Janssen Research & Development, LLC

INFO: https://clinicaltrials.gov/ct2/show/NCT04658862?recrs=abf&cond=Urothelial+Carcinoma&cntry=CA&draw=2&rank=6 

CONTACT:  844-434-4210

OTHER CANADIAN CENTRES:

1. The Male/Female Health and Research Centre (Barrie)                                  

2. University of Toronto:                                                                                                          

3. McGill University Health Centre (Montreal):                                                                  

4. CHU de Québec -L'Hôtel-Dieu de Québec (Québec City)                                                          

5. Centre Hospitalier Universitaire de Sherbrooke

Prostate | BC, QC | Recruiting
PR21
A Randomized Phase II Study of 177Lu-PSMA-617 vs Docetaxel in Patients with Metastatic Castration-Resistant Prostate Cancer and PSMA-Positive Disease
Dr. Francois Benard (BCCA), Dr. Kim Chi (BCCA), Dr. Fred Saad (CHUM)
Start Date: December 1, 2020

NCT #: NCT04663997

INFO: https://www.clinicaltrials.gov/ct2/show/NCT04663997

CONTACT:

(604) 675-8206

(604) 877-6000 x 2746

(514) 890-8000 x 27466

 

Renal | ON | Recruiting
PDXovo
Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid Tumors (PDXovo)
Dr. Georg Bjarnason (Sunnybrook Health Sciences Centre)
Start Date: December 1, 2020

NCT #: NCT04602702

SPONSOR: Sunnybrook Health Sciences Centre

INFO: https://clinicaltrials.gov/ct2/show/NCT04602702?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2

CONTACT: 416-480-6100 x 5748

OTHER CANADIAN CENTRES:  Odette Cancer Centre (Toronto)

Prostate | ON | Recruiting
ISTOP
Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer.
Dr. Patrick Cheung
Start Date: October 27, 2020

NCT #: NCT04619069

SPONSOR: Sunnybrook Health Sciences Centre 

INFO: https://clinicaltrials.gov/ct2/show/NCT04619069

CONTACT:  416-480-5000

Prostate | BC | Recruiting
PROTRACT
PROstate Cancer Treatment Optimization Via Analysis of Circulating Tumour DNA (PROTRACT)
Dr. Kim N. Chi
Start Date: October 7, 2020

NCT #: NCT04015622

SPONSOR: British Columbia Cancer Agency

INFO: https://www.clinicaltrials.gov/ct2/show/NCT05328505

CONTACT: 

1. Dr. Kim Chi (Vancouver) 6048776000 ext 672734 - kchi@bccancer.bc.ca                                                                       
2. Dr. Joanna Vergidis (Victoria) 2505195572 - Jvergidis@bccancer.bc.ca                                                                
3. Dr. Daygen Finch (Kelowna). 2507123900 - DFinch-02@bccancer.bc.ca                                                        
4. Dr. Krista Noonan (Surrey) 6049304064 - KNoonan2@bccancer.bc.ca

Other Canadian Centres:

1. BC Cancer - Vancouver Centre,                                                                 
2. BC Cancer - Victoria Centre                                                                       
3. BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre)                         
4. BC Cancer - Surrey Centre

Renal | AB, ON, QC | Recruiting
OC-001
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Oscellaris Pharma, Inc.
Start Date: October 6, 2020

NCT #: NCT04260802

SPONSOR: Ocellaris Pharma, Inc.

INFO: https://clinicaltrials.gov/ct2/show/NCT04260802?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=20

CONTACT:

317-651-7036

OTHER CANADIAN CENTRES: 

Cross Cancer Institute (Edmonton): 780-432-8248
Ottawa Hospital Cancer Centre (OHRI) Ottawa 613-737-7700 x 70185                  
Princess Margaret Hospital (Toronto): 416-946-2818                                    
Jewish General Hospital (Montreal): 514-340-8222 x 25981                                    
Centre hospitalier de l'Universite de Montreal (CHUM): 514-890-8000 x 30758

 

Renal | BC, ON | Recruiting
ELVCAP-001-01
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Elevation Oncology
Start Date: September 29, 2020

NCT #: NCT04383210

SPONSOR: Elevation Oncology

INFO:   https://clinicaltrials.gov/ct2/show/NCT04383210?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=30

CONTACT:  clinical@elevationoncology.com

OTHER CANADIAN CENTRES: 

Willian Osler Health System (Brampton)                                                       
Dr. Parneet Cheema: 416-747-3400

BC Cancer (Vancouver)                                                                                      
Dr. Janessa Laskin: 604-877-6000
 

 

Bladder | ON, QC | Recruiting
ARRAY-067-102
Study of PF-07265807 in Participants With Metastatic Solid Tumors
Pfizer
Start Date: September 24, 2020

NCT #: NCT04458259

SPONSOR: Pfizer

INFO: https://clinicaltrials.gov/ct2/show/NCT04458259?recrs=abf&cond=Urothelial+Carcinoma&cntry=CA&draw=2&rank=13

CONTACT: 1-800-718-1021

OTHER CANADIAN CENTRES:

1. Juravinski Cancer Centre (Hamilton)
2. University Health Network (Toronto)
3. CHU de Quebec-Universite Laval - Hotel Dieu de Quebec
4. Centre intégré de cancérologie du CHU de Québec Université Laval

Renal | ON | Active, not recruiting
D9950C00001 
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
AstraZeneca
Start Date: August 18, 2020

NCT #: D9950C00001

SPONSOR: AstraZeneca

INFO:  https://clinicaltrials.gov/ct2/show/NCT04504669?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=29

CONTACT:  information.center@astrazeneca.com

OTHER CANADIAN CENTRES: Edmonton & Toronto

 

 

 

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy